A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
Last updated:
Last updated
The date of the most recent update for each trial record in the Canadian Clinical Trial Search Portal.
2026-07-11
Language and content disclaimer
The content and search results on this site are collected from or provided by third parties. As such some of the information may only be available in the language originally submitted by the sponsor of the trial. Learn more about the information on the search portal.
Linking to Non-Government of Canada Websites
Links to websites not under the control of the Government of Canada, including those to our social media accounts, and to clinical trial records in international registries are provided solely for the convenience of our website visitors. We are not responsible for the accuracy, currency or reliability of the content of such websites. The Government of Canada does not offer any guarantee in that regard and is not responsible for the information found through these links, nor does it endorse the sites and their content.
Visitors should also be aware that information offered by non-Government of Canada sites to which this website links is not subject to the Privacy Act or the Official Languages Act and may not be accessible to persons with disabilities. The information offered may be available only in the language(s) used by the sites in question. With respect to privacy, visitors should research the privacy policies of these non-government websites before providing personal information.
EFFECTIVENESS AND SAFETY OF ONCE WEEKLY INSULIN ICODEC USED WITH DOSEGUIDE VERSUS ONCE DAILY BASAL INSULIN ANALOGUES IN AN INSULIN NAÏVE TYPE 2 DIABETES POPULATION IN A CLINICAL PRACTICE SETTING
Intervention/treatment:
Intervention/treatment
Name given to the drug used in the clinical trial. This may be a code name, a chemical name of the active ingredient, a non-proprietary name or brand name.
INSULIN ICODEC
Medical condition:
Medical condition
The disease or condition that's being studied in the clinical trial.
TYPE 2 DIABETES
Protocol code:
Protocol Code
An alpha-numeric sequence generated by the sponsor that can vary in length. Used as a reference to help identify a specific clinical trial protocol. Formerly referred to as 'protocol number'.
NN1436-4481
Control number:
Control number
A unique 6-digit identification number Health Canada assigns to each clinical trial application.
247022
Status:
Trial Status
The status for the clinical trial as a whole. Note that the status for each site may be different and should always be confirmed with the clinical trial sponsor. Health Canada uses information provided by the sponsor to an international clinical trial registry to determine status values for each clinical trial. Status values on the portal can include:
• Not yet recruiting - Participants are not yet being recruited or enrolled at any site. • Recruiting - Participants are currently being recruited. • Active, not recruiting - The clinical trial is ongoing but new participants are not currently being recruited or enrolled. • On hold - The clinical trial has been temporarily stopped, but it may start again. • Closed - The clinical trial has either ended normally and participants are no longer being examined or treated, or it has stopped early and will not start again. • Unknown - The status of the clinical trial has not been verified in the registry in the last 2 years. Please contact the sponsor. • No match, ongoing - Please contact sponsor for status information. • Other - Please contact sponsor for status information.
Closed
Approved:
Approved
The date that the clinical trial has been determined to meet Health Canada’s regulatory requirements. For drug clinical trials, this means that a no objection letter or an authorization was issued.
January 14, 2021
Date Completed:
Date completed
The date of the last participant’s last visit in the global study. The completion date may be actual or estimated, depending what was provided to the registry. Estimated completion dates may be in the past or future.
Trial phase:
Trial phase
The stage of a clinical trial, based on factors such as the objectives of the trial and number of participants. Phase data displayed in the portal is taken from international registry data.
For more information see "Phases of drug trials" on the Definitions webpage
This is an external link. The information is not authorized by the Government of Canada.
Eligibility
Eligibility
The characteristics people must have or the requirements they must meet to participate in the clinical trial. Eligibility criteria include both inclusion criteria (must have for a person to participate) and exclusion criteria (prevent a person from participating).
Review the exact criteria from the registry or the sponsor before making a decision to participate. The following values may be available on the portal:
Sex: an eligibility criteria based on biological characteristics. Information in the portal is based on available data and will default to 'all' when no other data is available.
Age: The age a person must be to participate in the clinical trial.
Accepts Healthy Volunteers: People who do not have the disease or condition can participate in the clinical trial.
Sex:
ALL
Age
Accepts healthy volunteers:
No
Contacts and locations
Contact
Contact
Information for an individual or organisation that can respond to questions about this clinical trial. This information comes from the international registry.
The sponsor conducts the clinical trial and is responsible for every aspect. For example this could be a company, a university or an individual researcher.
NOVO NORDISK CANADA INC
Locations
ALPHA Recherche Clinique
Québec, G3K 2P8
Centre de Recherche Saint-Louis
Québec, G1W 4R4
Diex Recherche Quebec
Québec, G1V 4T3
Recherche Clinique Sigma inc
Québec, G1G 5X1
Alberta
LMC Clin Res Inc. Calgary
Calgary, Alberta, T2H 2G4
The Bailey Clinic
Red Deer, Alberta, T4N 6V7
British Columbia
BC Diabetes Canada
Vancouver, British Columbia, V5Y 3W2
Dr. M.B. Jones Inc
Victoria, British Columbia, V8V 4A1
Ocean West Research Clinic
Surrey, British Columbia, V3Z 2N6
Saint Paul's Hospital
Vancouver, British Columbia, V6Z 1Y6
Manitoba
Rivergrove Medical Clinic
Winnipeg, Manitoba, R2V 4W3
Winnipeg Clinic
Winnipeg, Manitoba, R3C 0N2
New Brunswick
G.A. Research Associates Ltd.
Moncton, New Brunswick, E1G 1A7
Newfoundland and Labrador
Commonwealth Medical Clinic
Mount Pearl, Newfoundland and Labrador, A1N 1W7
Eastern Health Authority
St. John's, Newfoundland and Labrador, A1B 3V6
Ontario
Bluewater Clin Res Group,Inc
Sarnia, Ontario, N7T 4X3
Canadian Centre for Research on Diabetes
Smiths Falls, Ontario, K7A 4W8
Canadian Phase Onward Inc.
Toronto, Ontario, M3J 0K2
Centricity Research LMC (Toronto)
Brampton, Ontario, L6S 0C6
Dawson Clinical Research
Cambridge, Ontario, N1H 1B1
Dr. James Cha
Oshawa, Ontario, L1J 2K1
Dr Anil K Gupta Med Prof Corp
Toronto, Ontario, M9V 4B4
Enhanced Care Clinic
Oshawa, Ontario, L1J 1T4
Four Corners Walk-In Clinic
Greater Sudbury, Ontario, P3E 1Y8
Janik Research
Greater Sudbury, Ontario, P3B 4H5
Joanne F. Liutkus Medicine Professional Corporation
Cambridge, Ontario, N1R 7L6
Kawartha Cardiology Clinical Trials
Peterborough, Ontario, K9J 0B2
Keele Medical
Toronto, Ontario, M3M3E5
Leadership Sinai Centre for Diabetes, Mount Sinai Hospital